Report cover image

Italy Diabetes Drugs and Devices Market Size- By Management Devices, By Monitoring Devices- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Publisher SPER Market Research Pvt. Ltd.
Published Jun 18, 2024
Length 106 Pages
SKU # SPER19034482

Description

Italy Diabetes Drugs and Devices Market Size- By Management Devices, By Monitoring Devices- Regional Outlook, Competitive Strategies and Segment Forecast to 2033


Italy Diabetes Drugs and Devices Market Introduction and Overview

According to SPER market research, ‘Italy Diabetes Drugs and Devices Market Size- By Management Devices, By Monitoring Devices – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’state that the Italy Diabetes Drugs and Devices Market is predicted to reach USD 1.85 billion by 2033 with a CAGR of 6.31%.

A variety of pharmaceuticals and medical equipment together referred to as diabetes drugs and devices are used to control and treat diabetes mellitus, a chronic metabolic condition characterized by elevated blood sugar levels. Insulin, oral hypoglycemic medications, and injectable blood glucose-regulating therapies make up the pharmacological component.

The COVID-19 epidemic in Italy has significantly harmed diabetic care equipment. The epidemic brought to light opportunities for creating and extending diabetic care delivery. These included online consultations between diabetics and medical professionals as well as the use of diabetes technologies. hanks to crisis management, a number of long-standing regulatory restrictions have been loosened, and patients and doctors are now requesting remote care at a never-before-seen degree.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Management Devices, By Monitoring Devices

Regions covered Eastern Region, Western Region, Northern Region, Southern Region

Companies Covered

Abbott Diabetes Care, Arkray Inc., Ascensia Diabetes Care, Dexcom, Insulet Corporation, Eli Lilly, LifeScan Inc., Medtronic, Novo Nordisk A/S, Roche Diabetes Care, Rossmax International Ltd., Sanofi.

Italy Diabetes Drugs and Devices Market Segmentation:

By Management Devices: Based on the Management Devices, Italy Diabetes Drugs and Devices Market is segmented as; Insulin Pump, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors.

By Monitoring Devices: Based on the Monitoring Devices, Italy Diabetes Drugs and Devices Market is segmented as; Self-Monitoring Devices, Continuous Glucose Monitoring.

By Region:This research also includes data for Eastern Region, Western Region, Southern Region, Northern Region.

Table of Contents

106 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Italy Diabetes Drugs and Devices Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Italy Diabetes Drugs and Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Italy Diabetes Drugs and Devices Market
7. Italy Diabetes Drugs and Devices Market, By Management Devices (USD Million) 2020-2033
7.1. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Management Devices, 2020-2026
7.2. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Management Devices, 2027-2033
7.3. Insulin Pump
7.3.1. Insulin Pump device
7.3.2. Insulin Pump Reservoir
7.3.3. Infusion Set
7.4. Insulin Syringes
7.5. Cartridges in Reusable Pens
7.6. Insulin Disposable Pens
7.7. Jet Injectors
8. Italy Diabetes Drugs and Devices Market, By Monitoring Devices (USD Million) 2020-2033
8.1. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Monitoring Devices, 2020-2026
8.2. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Monitoring Devices, 2027-2033
8.3. Self-Monitoring Devices
8.3.1. Glucometer Devices
8.3.2. Blood Glucose Test Strips
8.3.3. Lancets
8.4. Continuous Glucose Monitoring
8.4.1. Sensors
8.4.2. Durables
9. Italy Diabetes Drugs and Devices Market Forecast, 2020-2033 (USD Million)
9.1. Italy Diabetes Drugs and Devices Market Size and Market Share
10. Italy Diabetes Drugs and Devices Market, By Region, 2020-2033 (USD Million)
10.1. Italy Diabetes Drugs and Devices Market Size and Market Share By Region (2020-2026)
10.2. Italy Diabetes Drugs and Devices Market Size and Market Share By Region (2027-2033)
10.3. Eastern Region
10.4. Northern Region
10.5. Eastern Region
10.6. Western Region
11. Company Profile
11.1. Abbott Diabetes Care
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Arkray Inc.
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Ascensia Diabetes Care
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Dexcom
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Insulet Corporation
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Eli Lilly
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. LifeScan Inc.
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Medtronic
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Novo Nordisk A/S
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Roche Diabetes Care
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Rossmax International Ltd.
11.11.1. Company details
11.11.2. Financial outlook
11.11.3. Product summary
11.11.4. Recent developments
11.12. Sanofi
11.12.1. Company details
11.12.2. Financial outlook
11.12.3. Product summary
11.12.4. Recent developments
11.13. Others
12. Conclusion
13. Reference Links
14. List of Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us